Ganoderma lucidum inhibits inducible nitric oxide synthase expression in macrophages

Molecular and Cellular Biochemistry

Volumn 275, Issue 1-2, 2005, Pages 165-171

  Woo, Connie W H ^a   Man, Ricky Y K ^a   Siow, Yaw L ^a,b   Choy, Patrick C ^a   Wan, Eric W Y ^a   Lau, Chak S ^b   O, Karmin ^a,b,c  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c ST BONIFACE GENERAL HOSPITAL   (Canada)

Author keywords

Herbal medicine; Inducible nitric oxide synthase; Nitric oxide; Oxidative stress

Indexed keywords

GANODERMA LUCIDUM EXTRACT; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; MESSENGER RNA; NITRIC OXIDE; REISHIMAX GLP; SUPEROXIDE;

ANTIOXIDANT ACTIVITY; ARTICLE; ATHEROSCLEROSIS; CELL LINE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; GANODERMA LUCIDUM; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; INCUBATION TIME; MACROPHAGE; PROTEIN EXPRESSION; WESTERN BLOTTING;

ANTIOXIDANTS; BLOTTING, WESTERN; CELL CULTURE TECHNIQUES; CELL LINE; DRUGS, CHINESE HERBAL; GENE EXPRESSION; HUMANS; MACROPHAGES; NITRATES; NITRIC OXIDE SYNTHASE TYPE II; NITRITES; PLANT EXTRACTS; REISHI; RNA, MESSENGER; SUPEROXIDES; TETRADECANOYLPHORBOL ACETATE;

GANODERMA LUCIDUM;

EID: 22044443080     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11010-005-1352-9     Document Type: Article

References (36)

1. Shiao M: Natural products of the medicinal fungus Ganoderma lucidum: occurrence, biological activities, and pharmacologial funtions. Chem Rec 3: 172-180, 2003
2. Miyazaki T, Nishijima M: Studies on fungal polysaccharides. XXVII. Structural examination of a water-soluble, antitumor polysaccharide of Ganoderma lucidum. Chem Pharm Bull 71: 115-124, 1981
3. Wang SY, Hsu ML, Hsu HC, Tzeng CH, Lee SS, Shiao MS, Ho CK: The anti-tumor effect of Ganoderma lucidum is mediated by cytokines released from activated marophages and T lymphocytes. Int J Cancer 70: 699-705, 1997
4. Lee SS, Wei YH, Chen CF, Wang SY, Chen KY: Antitumor effects of Ganoderma lucidum. J Chin Med 6: 1-12, 1995
5. Wasser SP, Weis AL: Medicinal properties of substances occurring in higher Basidiomycetes mushrooms: Current perspective (review). Int J Med Mushrooms 1: 31-62, 1999
6. Lin S, Li C, Lee S, Kan L: Triterpene-enriched extracts from Ganoderma lucidum inhibit growth of hepatoma cells via suppressing protein kinase C, activating mitogen-activated protein kinases and G2-phase cell cycle arrest. Life Sci 72: 2381-2390, 2003
7. Zhang H.N. Lin Z.B. Hypoglycemic effect of Gonaderma lucidum polysaccharides. Acta Pharmacol Sin 25(2): 191-195, 2004
8. Hsu MJ, Lee SS, Lee ST, Lin WW: Signaling mechanisms of enhanced neutrophil phagocytosis and chemotaxis by the polysaccharide purified from Ganoderma lucidum. Br J Pharmacol 139(2): 289-298, 2003
9. Zhu M, Chang Q, Wong LK, Chong FS, Li RC: Triterpene antioxidants from Ganoderma lucidum. Phytother Res 13: 529-531, 1999
10. Mau J, Lin H, Chen C: Antioxidant properties of several medicinal mushrooms. J Agric Food Chem 50: 6072-6077, 2002
11. Lee J, Kwon H, Jeong H, Lee JW, Lee SY, Baek SJ, Surh Y: Inhibition of lipid peroxidation and oxidative DNA damage by Ganoderma lucidum. Phytother Res 15: 245-249, 2001
12. Raji L, Baylis C: Glomerular actions of nitric oxide. Kidney Int 48(1): 20-32, 1995
13. Napoli C, Ignarro LJ: Nitric oxide and atherosclerosis. Nitric Oxide 5: 88-97, 2001
14. Radi R, Beckman JS, Bush KM, Freeman BA: Peroxynitrite-induced membrane lipid peroxidation: The cytotoxic potential of superoxide and nitric oxide. Arch Biochem Biophys 288: 481-487, 1991
15. White CR, Brock TA, Chang LT, et al.: Superoxide and peroxynitrite in atherosclerosis. Proc Natl Acad Sci USA 91: 1044-1048, 1994
16. Estévez A, Jordán J: Nitric oxide and superoxide, a deadly cocktail. Ann N Y Acad Sci 962: 207-211, 2002
17. Schussheim AE, Fuster V: Antibiotics for myocardial infarction? A possible role of infection in atherogenesis and acute coronary syndromes. Drug 57(3): 283-291, 1999
18. Rueckschloss U, Duerrschmidt N, Morawietz H: NADPH oxidase in endothelial cells: Impact on atherosclerosis. Antioxid Redox Signal 5(2): 171-180, 2003
19. Liu S, Adcock IM, Old RW, Barnes PJ, Evans TW: Lipopolysaccharide treatment in vivo induces widespread tissue expression of inducible nitric oxide synthase mRNA. Biochem Biophys Res Commun 196: 1208-1213, 1993
20. Cheung F, Siow YL, Karmin O: Inhibition by ginkgolides and bilobalide of the production of nitric oxide in macrophages (THP-1) but not in endothelial cells (HUVEC). Biochem Pharmacol 61: 503-510, 2001
21. Wang G, Siow YL, Karmin O: Homocysteine induces monocyte chemoattractant protein-1 expression by activating NF-kappa B in THP-1 macrophage. Am J Physiol Heart Cir Physiol 280: H2840-H2847, 2001
22. Kurosaka K, Watanabe N, Kabayashi Y: Production of proinflammatory cytokines by phorbol myristate acetate-treated THP-1 cells and monocyte-derived macrophages after phagocytosis of apoptotic CTLL-2 cells. J Immunol 161: 6245-6249, 1998
23. Wang N, Tabas I, Winchester R, Ravalli S, Rabbani LE, Tall A: Interleukin 8 is induced by cholesterol loading of macrophage and expressed by macrophage foam cells in human atheroma. J Biol Chem 271: 8837-8842, 1996
24. Michelakis ED, Archer SL: The measurement of NO in biological systems using chemiluminescene. In: M. Titheradge (ed.). Nitric Oxide Protocols, 1998, pp 111-127
25. Schmidt H, Kelm M: Determination of nitrite and nitrate by the griess reaction. In: M. Feelisch, J.S. Stamler (eds.). Methods in Nitric Oxide Research, 1996, pp 491-497
26. Bredti DS, Shmidt H: The Citrulline assay. In: M. Feelisch, J.S. Stamler (eds.). Methods in Nitric Oxide Research. J. Wiley: Chichester, New York, 1996, pp 249-255
27. Wang G, Siow YL, Karmin O: Homocysteine stimulates nuclear factor kappa B activity and monocyte chemoattractant protein-1 expression in vascular smooth muscle cells: A possible role for protein kinase C. Biochem J 352: 817-826, 2000
28. 2 formation. FASEB J 14: 1953-1964, 2000
29. Woo CW, Cheung F, Chan VW, Siow YL, Karmin O: Homocysteine stimulates inducible nitric oxide synthase expression in macrophages: Antagonizing effect of ginkgolides and bilobalide. Mol Cell Biochem 243(1-2): 37-47, 2003
30. Komoda Y, Shimizu M, Sonoda Y, Sato Y: Ganoderic acid and its derivatives as cholesterol synthesis inhibitors. Chem Pharm Bull (Tokyo) 37(2): 531-533, 1989
31. Kabir Y, Kimura S, Tamura T: Dietary effect of Ganoderma lucidum mushroom on blood pressure and lipid levels in spontaneously hypertensive rats (SHR). J Nutr Sci Vitaminol (Tokyo) 34(4): 433-438, 1998
32. Tao J, Feng KY: Experimental and clinical studies on inhibitory effect of Ganoderma lucidum on platelet aggregation. J Tongji Med Univ 10(4): 240-243, 1990
33. Khatri JJ, Johnson C, Magid R, Lessner SM, Laude KM, Dikalov SI, Harrison DG, Sung HJ, Rong Y, Galis ZS: Vascular oxidant stress enhances progression and angiogenesis of experimental atheroma. Circulation 109: 520-525, 2004
34. Juliet PA, Hayashi T, Daigo S, Matsui-Hirai H, Miyazaki A, Fukatsu A, Funami J, Iguchi A, Ignarro LJ: Combined effect of testosterone and apocynin on nitric oxide and superoxide production in PMA-differentiated THP-1 cells. Biochim Biophys Acta 1693(3): 185-191, 2004
35. Begarja AA, Wu D, Serafini M, Meydani SN: Mechanism of vitamin E inhibition of cyclooxygenase activity in macrophages from old mice: Role of peroxynitrite. Free Radic Biol Med 32(6): 503-511, 2002
36. Lancel S, Tissier S, Mordon S, Marechal X, Depontieu F, Scherpereel A, Chopin C, Neviere R: Peroxynitrite decomposition catalysts prevent myocardial dysfunction and inflammation in endotoxemic rats. J Am Coll Cardiol 43(12): 2348-2358, 2004